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Abstract
Background: Observational studies show moderate alcohol use negatively associated with ischemic heart disease (IHD) and
cardiovascular disease (CVD). However, healthier attributes among moderate users compared to never users may confound
the apparent association. A potentially less biased way to examine the association is Mendelian randomization, using
alcohol metabolizing genes which influence alcohol use.
Methods: We used instrumental variable analysis with aldehyde dehydrogenase 2 (ALDH2) genotypes (AA/GA/GG) as
instrumental variables for alcohol use to examine the association of alcohol use (10 g ethanol/day) with CVD risk factors
(blood pressure, lipids and glucose) and morbidity (self-reported IHD and CVD) among men in the Guangzhou Biobank
Cohort Study.
Results: ALDH2 genotypes were a credible instrument for alcohol use (F-statistic 74.6). Alcohol was positively associated
with HDL-cholesterol (0.05 mmol/L per alcohol unit, 95% confidence interval (CI) 0.02 to 0.08) and diastolic blood pressure
(1.15 mmHg, 95% CI 0.23 to 2.07) but not with systolic blood pressure (1.00 mmHg, 95% CI -0.74 to 2.74), LDL-cholesterol
(0.03 mmol/L, 95% CI -0.03 to 0.08), log transformed triglycerides (0.03 mmol/L, 95% CI -0.01 to 0.08) or log transformed
fasting glucose (0.01 mmol/L, 95% CI -0.006 to 0.03), self-reported CVD (odds ratio (OR) 0.98, 95% CI 0.76 to 1.27) or self-
reported IHD (OR 1.10, 95% CI 0.83 to 1.45).
Conclusion: Low to moderate alcohol use among men had the expected effects on most CVD risk factors but not fasting
glucose. Larger studies are needed to confirm the null associations with IHD, CVD and fasting glucose.
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Introduction
In observational studies alcohol usually has a U or J shaped
association with health, such that moderate alcohol use (1–2 drinks
per day) is negatively associated with ischemic heart disease (IHD)
[1] ischemic stroke [2] and diabetes [3]. Correspondingly, some
public health advice implies that moderate alcohol use is protective
against cardiovascular disease (CVD) and diabetes [4]. However,
observational studies are vulnerable to biases from residual
confounding, due to unmeasured systemic differences between
moderate alcohol and other alcohol users [5], from over-
adjustment due to an imperfect understanding of the underlying
causal pathways and from reverse causality, thus such studies may
not provide a sound basis for causal inference. Notably, the
benefits of moderate alcohol use are not always evident in studies
from the majority of the global population outside western settings
[6–8] where moderate alcohol use is less commonly used as a
social lubricant.
Evidence from randomized controlled trials (RCTs) suggests
that alcohol monotonically increases blood pressure [9,10], high
density lipoprotein (HDL)-cholesterol [11] and triglycerides [11],
whilst the evidence concerning diabetes and glucose metabolism is
more limited [12,13]. There have been no large-scale RCTs of
moderate alcohol use and cardiovascular disease most likely due to
ethical and practical issues. A Mendelian randomization study
provides an alternative approach to establish the causal role of
moderate alcohol use in a suitable population where a genetic
variant affects alcohol metabolism and thereby alcohol use.
Genetic variants in the aldehyde dehydrogenase 2 (ALDH2) gene
do affect alcohol metabolism [14] and have been proposed as
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suitable predictors of alcohol use for use in Mendelian random-
ization studies [15]. Mendelian randomization studies can be
thought of in three ways. First, the genotypes can serve as proxies
of the exposure [15], which is particularly useful if the relevant
exposure has not been or cannot be measured. Second, Mendelian
randomization can be thought of as triangulation of genotype,
exposure and outcome, akin to mediation, which is an intuitive
way of thinking of instrumental variable analysis. Third, Mende-
lian randomization can be thought of as instrumental variable
analysis with genetic instruments, which was used in this study
[16,17], because instrumental variable analysis is a well-established
statistical technique with known statistical assumptions and
properties. ALDH2 alleles are randomly allocated to at conception.
People with inactive ALDH2 alleles flush and feel discomfort
following alcohol use because of acetaldehyde exposure [18].
Genetically determined alcohol use resembles random allocation
in RCTs, and provides a potentially less biased way to assess the
effect of moderate alcohol use on health [15]. People, with inactive
ALDH2 alleles, and correspondingly lower alcohol consumption,
have been observed to have lower blood pressure [19] and lower
HDL-cholesterol [20], consistent with evidence from RCTs.
However these studies lacked information on alcohol use and
used ALDH2 genotypes as proxies of alcohol consumption, rather
than using instrumental variable analysis to estimate the effect of
alcohol use on CVD risk factors.
Southern Chinese men are uniquely suitable for a Mendelian
randomization study of alcohol use with ALDH2 genotype as a
genetic instrument. Inactive alleles of ALDH2 are common in East
Asia. In our study of Southern Chinese ALDH2 alleles are
consistent with Hardy Weinberg equilibrium as required for
Mendelian randomization [21]. ALDH2 was also strongly associ-
ated with alcohol use among men but not associated with potential
confounders [21]. We used Mendelian randomization to assess
whether moderate alcohol use was protective against self-reported
CVD, self-reported IHD or major CVD risk factors among men
from the Guangzhou Biobank Cohort Study. We also assessed the
same associations using multivariable regression adjusted for
confounders in an observational study design for comparison.
Methods
Ethics statement
The Guangzhou Medical Ethics Committee of the Chinese
Medical Association approved the study and all participants gave
written, informed consent before participation.
Participants
The Guangzhou Biobank Cohort Study (GBCS) is a collabo-
ration between the Guangzhou No.12 Hospital and the Univer-
sities of Hong Kong and Birmingham [22]. Recruitment of
participants draws from ‘‘The Guangzhou Health and Happiness
Association for the Respectable Elders (GHHARE)’’, a community
social and welfare association unofficially aligned with the
municipal government where membership is open to anyone aged
50 years or older for a monthly, nominal fee of 4 Yuan (50 US
cents). There were three recruitment phases. Recruitment for
phase 1 took place from September 2003 to November 2004, for
phase 2 from April 2005 to May 2006, and for phase 3 from
September 2006 to January 2008. Follow-up of the participants
started in 2008. Approximately 7% of permanent Guangzhou
residents aged 50 years or more are members of GHHARE, of
whom 33% enrolled for phases 1, 2 or 3 recruitment and were
included if they were capable of consenting, ambulatory, and not
receiving treatment modalities that, if omitted, may result in
immediate life-threatening risk, such as chemotherapy or radio-
therapy for cancer, or dialysis for renal failure. Participants in
GBCS are ethnic Chinese largely from southern China. Partici-
pants underwent a detailed interview and physical examination at
baseline recruitment, including medical history and report of
doctor diagnosed conditions. Participants were asked about doctor
diagnosed CVD, and if applicable the type of CVD, such as IHD
or stroke. The methods of measurement have previously been
reported [22]. Alcohol use was recorded in terms of frequency,
type of beverage and usual amount per occasion. We recorded
seated blood pressure as the average of the last two or three
measurements, using the Omron 705CP sphygmomanometer
(Omron Corp., Kyoto, Japan). Fasting low density lipoprotein
(LDL)-cholesterol, high density lipoprotein (HDL)-cholesterol,
triglycerides, and glucose were determined with a Shimadzu CL-
8000 clinical chemical analyzer (Shimadzu Corp, Kyoto, Japan) in
the hospital laboratory.
DNA extraction and SNP analysis
As previously described [21], biological samples for DNA
extraction used in the present study were obtained in GBCS phase
3 at recruitment and in phases 1 and 2 at follow-up. Of the 8,450
men in all three GBCS phases, 5,606 had bio-materials suitable for
DNA extraction. DNA was extracted at Guangzhou No. 12
Hospital either from fresh blood using a standard phenol-
chloroform extraction procedure and stored at 280uC or from
blood or buffy coat previously stored at 280uC using a standard
magnetic bead extraction procedure. There were 4,987 men with
viable DNA for genotyping. Genotyping of SNP rs671 to identify
ALDH2 genotypes (AA, GA or GG) was performed using the
MassARRAY system (Sequenom, San Diego, CA, USA) and the
iPLEX assay at a commercial company (Beijing CapitalBio
Corporation, Beijing, China).
Alcohol use
The main exposure was continuous alcohol units (10 gram (g)
ethanol per day) based on total alcohol consumption obtained
from the frequency, quantity and type recorded at recruitment
[21]. Specifically, we asked the participants how often they drank
alcohol (once or twice per year, once every couple of months,
,1 day/ week, 1–2 days/week, 3–4 days/week, 5–6 days/week,
daily or almost every day), the type of alcohol usually consumed,
and how much of each type of alcohol (beer, western table wine,
spirits, Chinese rice wine or Chinese rice wine (high strength))
usually consumed per occasion, from which we calculated units
per day. Infeasible amounts (.30 alcohol units per day) were
excluded [21]. Former alcohol users were included as non-drinkers
because former alcohol users may have abstained from alcohol
because of poor health unrelated to former alcohol use; excluding
them could create a bias. Many former users reported previously
infrequent alcohol use, i.e., once or twice a year.
Outcomes
The outcomes were doctor diagnosed self-reported CVD, which
included IHD, stroke/transient ischemic attack, angina, myocar-
dial infarction, peripheral vascular disease, valvular heart disease
and rheumatic heart disease, self-reported IHD, which included
IHD, angina and myocardial infarction, and biological CVD risk
factors, i.e., systolic blood pressure, diastolic blood pressure, HDL-
cholesterol, LDL-cholesterol and fasting plasma glucose, reflecting
biological risk factors in the Framingham equation. We also
included a related risk factor, triglycerides, because alcohol use has
been positively associated with triglycerides in RCTs [11]. Since
Alcohol and CVD Using Mendelian Randomization
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triglycerides and fasting glucose were not normally distributed,
they were log transformed.
Statistical analysis
We used analysis of variance (ANOVA) to assess the associa-
tions of ALDH2 genotypes with alcohol consumption, blood
pressure and body mass index. We used chi-square tests to assess
whether ALDH2 genotypes were associated with potential
confounders, such as socioeconomic position, lifestyle, and
medication use. We used instrumental variable analysis (2 stage
least squares (2SLS)) with ALDH2 genotype categories as an
instrumental variable, because there was a non-linear association
with alcohol consumption, to obtain estimates of alcohol use on
CVD risk factors, from which we reported b coefficients with 95%
confidence intervals. Such b coefficients represent the effect of one
unit of alcohol on the CVD risk factor. This instrumental variable
analysis obtains the effect of alcohol use on each CVD risk factor
from the association of ALDH2 with the CVD risk factor divided
by the association of ALDH2 with alcohol use, i.e., by using the
relations between genotype, alcohol use and CVD risk factors. For
CVD morbidity, we used instrumental variable probit regression
analysis to obtain the probit coefficient, which we multiplied by 1.6
to obtain the approximate logarithm of the odds ratio [23]. We did
not adjust for confounders in 2SLS or the instrumental variable
probit regression because ALDH2 genotypes randomly allocated at
conception cannot be confounded by age or subsequent socio-
economic position, lifestyle or medication use. Figure 1 depicts the
directed acyclic graph for the Mendelian randomization analyses,
i.e., instrumental variable analysis with genetic instruments, used
in this study.
For comparison, we also present the adjusted associations of
alcohol units with the outcomes under multivariable regression
models in an observational design. We adjusted these multivar-
iable regression models for age, education, physical activity,
smoking status and additionally adjusted analysis of CVD risk
factors for use of appropriate medication.
Sensitivity analyses
We repeated the analysis excluding former users in a sensitivity
analysis. Instrumental variable analysis assumes linear association
between alcohol and the CVD. To account for any potential U
shaped relation of alcohol use with CVD, we also repeated the
analysis excluding heavy users (weekly drinking .210 g ethanol/
week) because alcohol use below this level is usually more
monotonic, and so can be modeled as linear.
All statistical analyses were conducted using Stata version 10.1
(StataCorp LP, College Station, TX).
Results
Of the 4,987 men with viable DNA, 4,867 had complete
information on ALDH2 genotypes, alcohol use and at least one
outcome. Table 1 shows that men with two active ALDH2 alleles
on average consumed ten times as much alcohol per day (0.9 units)
as men with two inactive alleles (0.09 units). Fifty one percent
(51%) of men were never users. Among current users, the mean
alcohol units consumed was 1.30 (standard deviation 2.88) while
the main alcohol beverage type used was Chinese rice wine (64%).
Relatively few men reported IHD (4.8%) or CVD (6.4%)
consistent with mortality from these causes in China [24]. ALDH2
satisfies the assumptions for being a credible instrument for alcohol
use, including little direct association with the outcomes consid-
ered [25], and little association with potential confounders, such as
age, socioeconomic positions and lifestyle (Table 1).
The F-statistic from the first stage of the instrumental variable
analysis was 74.6 (r2 = 0.03), suggesting that weak instrument bias
was unlikely. There was no evidence that the association of
ALDH2 genotypes with alcohol units varied with any of the
outcomes considered. Table 2 shows that in the Mendelian
randomization analysis alcohol was positively associated with
diastolic blood pressure, and HDL-cholesterol. Alcohol was not
associated with systolic blood pressure, LDL-cholesterol, log
transformed triglycerides, log transformed fasting plasma glucose,
self-reported IHD or self-reported CVD.
Most of the observational estimates from multivariable regres-
sion were in the same direction as, but smaller than, the
Mendelian randomization estimates. Alcohol was also positively
associated with systolic blood pressure, LDL-cholesterol, and
fasting glucose, but was not associated with self-reported CVD or
self-reported IHD. Associations were similar when former users
were excluded (Table 3) although estimates were larger when
heavy users were excluded (Table 4). Table 5 shows analysis
stratified by age, because genetic associations may be less evident
at older ages when aging and ill-health may have a greater impact
on CVD and its risk factors. The effects of alcohol were more
evident among the younger men.
Discussion
Using a Mendelian randomization design, which utilizes genes
randomly allocated at conception and is similar to the random
allocation process of an RCT [16], in a suitable low to moderate
drinking population of Southern Chinese men, we found low to
moderate alcohol use led to higher diastolic blood pressure, and
HDL-cholesterol, with no protective effect on fasting glucose, self-
reported CVD or self-reported IHD. Our results are consistent
with experimental and non-observational evidence showing that
alcohol monotonically increases blood pressure [10,19] and HDL-
cholesterol [11] with no protective effect on glucose metabolism
[26], although previous studies on glucose metabolism were not
powered to detect a small effect [13]. Our study adds by
confirming these findings in the first comprehensive Mendelian
randomization analysis of the causal effects of moderate alcohol
use on CVD, IHD and CVD risk factors. It also adds by showing,
for the first time, that moderate alcohol use might not have a
protective effect on IHD or CVD morbidity although larger
studies are required to confirm these preliminary null findings.
A Mendelian randomization study design may provide a better
means of generating an unbiased estimate, given systematic
differences among alcohol users. However, limitations of this
study remain. First, the effects of alcohol could vary by ALDH2
genotype due to varying acetaldehyde exposure. However animal
studies suggest acetaldehyde causes cardiovascular harm [27],
Figure 1. Directed acyclic graph showing the framework of
Mendelian randomization analyses in this study.
doi:10.1371/journal.pone.0068054.g001
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which, if anything, would bias towards a protective effect of active
ALDH2 alleles and hence of alcohol. Second, Mendelian
randomization studies in western populations, where beneficial
effects of moderate alcohol use have most consistently been
observed, might be most convincing. However, Caucasians lack
ALDH2 (rs671) polymorphisms and such studies would need to use
ADH polymorphisms which have weaker associations with alcohol
use in Chinese [28]. Third, the range of alcohol use was mainly
low to moderate, beyond which our findings should not be
extrapolated. A meta analysis of observational studies on alcohol
use and cardiovascular outcomes suggest benefits of alcohol use
was observed within this range [1]. Fourth, Mendelian random-
ization studies require large sample sizes for adequate power.
Power calculation for Mendelian randomization analyses is not
readily available. In the current Mendelian randomization analysis
of ,4,500 men, the r2 (squared correlation) for ALDH2 genotypes
with alcohol units was 0.03. Based on a recent simulation study,
our analysis would be powered to detect effect sizes of at least 0.3
Table 1. Alcohol consumption and socio-demographic characteristics by ALDH2 genotype among men from the Guangzhou
Biobank Cohort Study (2003–8).
ALDH2 genotype (from rs671)
Two inactive alleles (AA) One inactive allele (AG/GA) No inactive alleles (GG) 1P value
Alcohol units (10g n 416 2,023 2,428
ethanol) per day mean (SD) 0.09 (0.79) 0.24 (1.22) 0.90 (2.52) ,0.001
Age group (%) years n, years 417 2,053 2,457
50–54 11.0 10.0 9.2 0.41
55–59 20.9 20.9 21.2
60–64 25.9 23.9 26.3
65–69 19.7 23.8 23.4
70–74 16.3 15.7 14.6
75–79 5.5 4.2 3.7
80+ 0.7 1.5 1.4
Education (%) n 417 2,051 2,455
Less than primary 2.6 2.3 2.3 0.63
Primary 24.7 27.3 26.2
Junior middle 29.0 30.3 31.1
Senior middle 27.1 25.1 23.5
Junior college 10.3 8.5 9.2
College 6.2 6.5 7.7
Smoking status (%) n 416 2,045 2,444
Never 41.1 40.4 40.1 0.88
Former 29.3 27.7 27.8
Current 29.6 31.9 32.2
Physical activity n 417 2,053 2,457
(IPAQ) (%) Inactive 9.1 8.5 8.1 0.23
Minimally active 36.9 38.8 41.6
{HEPA active 54.0 52.7 50.3
Antihypertensive n 416 2,045 2,451
drugs (%) Current user 19.5 18.7 20.2 0.49
Lipid modifying n 417 2,052 2,453
drugs (%) Current user 5.5 5.4 6.3 0.44
drugs (%) Current user 6.2 6.2 6.6 0.87
Systolic blood n 416 2,046 2,449
pressure (mmHg) mean (SD) 131.2 (19.3) 132.7 (21.1) 133.0 (21.7) 0.31
Diastolic blood n 415 2,046 2,446
pressure (mmHg) mean (SD) 75.3 (10.4) 75.8 (10.9) 76.5 (11.4) 0.05
Body Mass n 416 2,048 2,448
Index (kg/m2) mean (SD) 23.5 (3.0) 23.5 (3.1) 23.5 (3.2) 0.84
1P-value from ANOVA for continuous variables and from a x2 test for categorical variables, 2 sided.
{HEPA: health-enhancing physical activity (i.e., vigorous activity at least 3 days a week achieving at least 1,500 metabolic equivalent (MET) minutes per week or activity
on 7 days of the week, achieving at least 3,000 MET minutes per week; IPAQ: International Physical Activity Questionnaire.
doi:10.1371/journal.pone.0068054.t001
Alcohol and CVD Using Mendelian Randomization
PLOS ONE | www.plosone.org 4 July 2013 | Volume 8 | Issue 7 | e68054
standard deviations [29], and analyses for CVD risk factors should
be adequately powered. On the other hand, given the low
prevalence of self-reported CVD and IHD in this study, the
relevant analyses were likely to be underpowered and hence we
only considered these analyses as preliminary. These analyses
should be replicated in future studies with larger sample size. Fifth,
this is not a population representative study, however, disease
prevalence is similar to that in a representative urban Chinese
population [22]. The generalizability of this study will be limited if
amongst the men excluded from this study the effect of genetically
determined alcohol use on CVD and its risk factors differed from
that in the men included, which is unlikely. We did not have
suitable bio-materials for all men from phases 1 and 2. However,
ALDH2 genotypes were not associated with recruitment phase.
Sixth, grape wine was rarely consumed (,10% of all current
alcohol users) but the apparent benefits of alcohol appear to be
independent of beverage types, where the rise in HDL-cholesterol
is similar across beverage types [30]. Although the additional
benefits from wine consumption could be due to resveratrol, or to
confounding by socioeconomic position biasing the estimates from
null [31], wine use is rare in Southern China, so our study is
particularly suitable for establishing the effects of alcohol use.
Seventh, we do not yet have prospective CVD events in this study.
However, we used self-reported CVD and self-reported IHD,
which have previously been shown to be associated with the
metabolic syndrome in this study, indicating some validity of these
self reports [32]. However, misclassification of CVD events arising
from self-reports may have made it more difficult to detect any
association resulting in the observed null associations. Eighth,
Mendelian randomization studies assess the causal effects of
exposure on outcome, Mendelian randomization studies do not
address exactly how any causal effect is mediated. For example our
null association of alcohol use with CVD is consistent with positive
effects of alcohol on blood pressure being balanced out by positive
effects on HDL, but could have occurred by other mechanisms,
which is of etiological relevance and needs to be assessed.
However, from a public health perspective the key question is
the effect of alcohol regardless of how it is mediated. Ninth,
Mendelian randomization studies require no direct association of
the instrument with confounders or the outcomes, as well as
homogenous associations and lack of population stratification [33].
We found no evidence of direct associations of the instrument with
confounders in our previous Mendelian randomization study [21]
or any direct genetic associations with the outcomes among a
random sample of women who were mostly never/occasional
users (data not shown). Our study was drawn from permanent
residents of Guangzhou who are ethnically homogeneous.
Nevertheless, as with any study, we cannot rule out all possible
biases. In addition, Mendelian randomization requires additional
assumptions and some of them are not always verifiable [33].
Tenth, we did not test for a curvilinear association of alcohol use
with CVD or its risk factors as instrumental variable analysis
assumes linearity between alcohol and the outcomes. On the other
hand, in our setting alcohol use is generally low and in the range
where the observed associations of alcohol use with CVD and its
risk factors are usually linear. However, we presented an
additional analysis excluding heavy users (Table 4), which gave a
similar interpretation. In additional, although observational
associations may be curvilinear, causal effects are more often
linear, such that a dose-response relation is one of the Bradford
Hill criteria for causality. Eleventh, genetic associations with
health may be less evident at older ages, potentially creating a bias
towards the null. In age-stratified analysis the effects of alcohol onT
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CVD and its risk factors were most evident in the younger men
(Table 5).
Despite these limitations, our findings for CVD risk factors are
similar in direction and interpretation to those from non-
observational studies. The Mendelian randomization estimates of
the effect of one alcohol unit (10 g of ethanol per day) on diastolic
blood pressure and HDL-cholesterol were higher than those
reported from RCTs [10,11]. Most RCTs of alcohol use concern
free-living people in western populations. Any lapse in compliance
would underestimate the effect of alcohol. Moreover, the effect of
reducing from high alcohol consumption, as often examined [9],
may not be the same as increasing from negligible or low alcohol
consumption. Prior lifelong alcohol use may also compromise
these inevitably short trials [10,11]. Our estimates also had wide
confidence intervals, which included estimates from intervention
studies [9,11]. However, it is possible that the differences in the
estimates between our study and RCTs could be due to differences
in the participants studied in these designs or violations of the
instrumental variable assumptions [33], although we have
established the credibility of ALDH2 as an instrumental variable
for alcohol use [25], or possible over-estimation of the magnitude,
but not direction, of the Mendelian randomization estimate from
instrumental variable analysis [34]. Instrumental variable analyses
estimates generated as the association of genetic variant with the
outcome divided by the association of genetic variant with the
exposure may be inflated by reverse causality if the outcome affects
the exposure in such a way as to reduce the association of the
genetic variant with the exposure.
Our results suggest that moderate alcohol use has no effect on
CVD, IHD or fasting glucose, which is different from western
observational studies where moderate alcohol use is associated
with lower morbidity or mortality from CVD and diabetes [1–3].
However, these findings from western settings have not always
been replicated in non-western settings [6–8]. Such discrepancies
might indicate that any observed protective effects in western
contexts are due to confounding rather than to the biological
properties of alcohol although the null results, in particular for
CVD and IHD, had limited statistical power and do not preclude
small protective effects. Alternatively, given that moderate alcohol
use has both healthy and unhealthy effects on CVD risk factors the
net effect may depend on the CVD risk profile in any given
population [35]. Higher HDL-cholesterol is thought to underlie
the cardioprotection of moderate alcohol use [36]. However, the
causal role of HDL-cholesterol has been challenged by a recent
meta regression analysis of RCTs of lipid modifying drugs and by
two Mendelian randomization studies where genetically higher
HDL-cholesterol had little effect on IHD [37–39]. The mecha-
nistic pathway by which alcohol confers cardioprotection may
need to be extended beyond HDL-cholesterol. Lower respiratory
mortality has been observed with moderate alcohol use, with
corresponding implications for CVD morbidity and mortality
[40]. Respiratory benefits of alcohol may occur via anti-
inflammatory pathways [41]. Alternatively, alcohol reduces
testosterone [42], which would be expected to reduce inflamma-
tion [43], giving a possible pathway. However, to our knowledge
whether alcohol operates via these pathways has not been
comprehensively assessed.
From a public health perspective, our study using a potentially
less biased design, suggests no benefit of moderate alcohol use on
CVD, IHD or some CVD risk factors including fasting glucose.
On the other hand, our null associations of moderate alcohol use
with IHD and CVD might suggest a non-causal role of moderate
alcohol use, but had limited statistical power. Larger studies are
needed to confirm these findings.
T
a
b
le
4
.
M
e
n
d
e
lia
n
ra
n
d
o
m
iz
at
io
n
e
st
im
at
e
s,
o
b
ta
in
e
d
fr
o
m
in
st
ru
m
e
n
ta
l
va
ri
ab
le
an
al
ys
is
u
si
n
g
2
SL
S
an
d
p
ro
b
it
re
g
re
ss
io
n
,
an
d
m
u
lt
iv
ar
ia
b
le
lin
e
ar
an
d
p
ro
b
it
re
g
re
ss
io
n
e
st
im
at
e
s
o
f
th
e
as
so
ci
at
io
n
o
f
al
co
h
o
l
u
se
(1
u
n
it
)
w
it
h
C
V
D
ri
sk
fa
ct
o
rs
an
d
m
o
rb
id
it
y,
e
xc
lu
d
in
g
h
e
av
y
u
se
rs
.
M
e
n
d
e
li
a
n
ra
n
d
o
m
iz
a
ti
o
n
In
st
ru
m
e
n
ta
l
v
a
ri
a
b
le
a
n
a
ly
si
s
{O
b
se
rv
a
ti
o
n
a
l
M
u
lt
iv
a
ri
a
b
le
re
g
re
ss
io
n
n
1
b
9
5
%
C
I
p
v
a
lu
e
n
1
b
9
5
%
C
I
p
v
a
lu
e
Sy
st
o
lic
b
lo
o
d
p
re
ss
u
re
(m
m
H
g
)
4
,5
6
8
1
.3
0
2
6
.0
1
to
8
.6
1
0
.7
3
4
,5
6
2
2
.2
9
1
.0
7
to
3
.5
0
,
0
.0
0
1
D
ia
st
o
lic
b
lo
o
d
p
re
ss
u
re
(m
m
H
g
)
4
,5
6
4
3
.7
3
2
0
.1
1
to
7
.5
7
0
.0
6
4
,5
5
8
1
.7
4
1
.0
8
to
2
.3
9
,
0
.0
0
1
Lo
g
tr
an
sf
o
rm
e
d
tr
ig
ly
ce
ri
d
e
s
(m
m
o
l/
L)
4
,5
5
9
0
.0
9
2
0
.1
0
to
0
.2
8
0
.3
4
4
,5
5
2
0
.0
0
2
0
.0
3
to
0
.0
3
0
.9
6
H
D
L-
ch
o
le
st
e
ro
l
(m
m
o
l/
L)
4
,5
5
8
0
.1
6
0
.0
3
to
0
.2
9
0
.0
1
4
,5
5
1
0
.0
5
0
.0
3
to
0
.0
8
,
0
.0
0
1
LD
L-
ch
o
le
st
e
ro
l
(m
m
o
l/
L)
4
,5
5
3
0
.0
9
2
0
.1
4
to
0
.3
1
0
.4
5
4
,5
4
6
2
0
.0
1
2
0
.0
5
to
0
.0
3
0
.6
1
Lo
g
tr
an
sf
o
rm
e
d
fa
st
in
g
g
lu
co
se
(m
m
o
l/
L)
4
,5
5
2
0
.0
2
2
0
.0
5
to
0
.0
9
0
.5
5
4
,5
4
5
0
.0
1
0
.0
0
2
to
0
.0
2
0
.0
2
n
O
d
d
s
ra
ti
o
9
5
%
C
I
p
v
a
lu
e
n
O
d
d
s
ra
ti
o
9
5
%
C
I
p
v
a
lu
e
Se
lf
-r
e
p
o
rt
e
d
C
V
D
4
,5
8
0
0
.9
4
0
.3
2
to
2
.8
1
0
.9
2
4
,5
7
7
0
.8
4
0
.6
7
to
1
.0
6
0
.1
4
Se
lf
-r
e
p
o
rt
e
d
IH
D
4
,5
8
0
1
.6
7
0
.5
3
to
5
.2
3
0
.3
8
4
,5
7
7
0
.8
0
0
.6
2
to
1
.0
5
0
.1
0
{ a
d
ju
st
e
d
fo
r
ag
e
,
e
d
u
ca
ti
o
n
,
p
h
ys
ic
al
ac
ti
vi
ty
,
sm
o
ki
n
g
an
d
u
se
o
f
ap
p
ro
p
ri
at
e
m
e
d
ic
at
io
n
(C
V
D
ri
sk
fa
ct
o
rs
o
n
ly
).
1
p
e
r
al
co
h
o
l
u
n
it
ch
an
g
e
(1
0
g
ra
m
s
e
th
an
o
l/
d
ay
).
"
O
d
d
s
ra
ti
o
is
ap
p
ro
xi
m
at
e
d
b
y
th
e
an
ti
lo
g
ar
it
h
m
o
f
(1
.6
6
p
ro
b
it
co
e
ff
ic
ie
n
t)
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
6
8
0
5
4
.t
0
0
4
Alcohol and CVD Using Mendelian Randomization
PLOS ONE | www.plosone.org 7 July 2013 | Volume 8 | Issue 7 | e68054
T
a
b
le
5
.
M
e
n
d
e
lia
n
ra
n
d
o
m
iz
at
io
n
e
st
im
at
e
s,
o
b
ta
in
e
d
fr
o
m
in
st
ru
m
e
n
ta
l
va
ri
ab
le
an
al
ys
is
u
si
n
g
2
SL
S
an
d
p
ro
b
it
re
g
re
ss
io
n
,
an
d
m
u
lt
iv
ar
ia
b
le
lin
e
ar
an
d
p
ro
b
it
re
g
re
ss
io
n
e
st
im
at
e
s
o
f
th
e
as
so
ci
at
io
n
o
f
al
co
h
o
l
u
se
(1
u
n
it
)
w
it
h
C
V
D
ri
sk
fa
ct
o
rs
an
d
m
o
rb
id
it
y
st
ra
ti
fi
e
d
b
y
m
e
d
ia
n
ag
e
.
M
e
n
d
e
li
a
n
ra
n
d
o
m
iz
a
ti
o
n
In
st
ru
m
e
n
ta
l
v
a
ri
a
b
le
a
n
a
ly
si
s
{O
b
se
rv
a
ti
o
n
a
l
M
u
lt
iv
a
ri
a
b
le
re
g
re
ss
io
n
A
g
e
g
ro
u
p
C
V
D
ri
sk
fa
ct
o
r
o
r
m
o
rb
id
it
y
n
1
b
9
5
%
C
I
p
v
a
lu
e
n
1
b
9
5
%
C
I
p
v
a
lu
e
A
g
e
!
6
3
.5
Sy
st
o
lic
b
lo
o
d
p
re
ss
u
re
(m
m
H
g
)
2
,4
3
0
3
.0
8
0
.4
7
to
5
.6
9
0
.0
2
2
,4
2
8
0
.8
6
0
.4
8
to
1
.2
4
,
0
.0
0
1
A
g
e
.
6
3
.5
Sy
st
o
lic
b
lo
o
d
p
re
ss
u
re
(m
m
H
g
)
2
,4
2
3
2
0
.5
7
2
2
.9
2
to
1
.7
9
0
.6
4
2
,4
1
9
0
.8
4
0
.4
2
to
1
.2
7
,
0
.0
0
1
A
g
e
!
6
3
.5
D
ia
st
o
lic
b
lo
o
d
p
re
ss
u
re
(m
m
H
g
)
2
,4
2
8
2
.3
4
0
.8
2
to
3
.8
7
0
.0
0
3
2
,4
2
6
0
.4
6
0
.2
4
to
0
.6
8
,
0
.0
0
1
A
g
e
.
6
3
.5
D
ia
st
o
lic
b
lo
o
d
p
re
ss
u
re
(m
m
H
g
)
2
,4
2
1
0
.0
6
2
1
.0
9
to
1
.2
1
0
.9
2
2
,4
1
7
0
.5
2
0
.3
1
to
0
.7
3
,
0
.0
0
1
A
g
e
!
6
3
.5
Lo
g
tr
an
sf
o
rm
e
d
tr
ig
ly
ce
ri
d
e
s
(m
m
o
l/
L)
2
,4
2
4
0
.0
4
2
0
.0
3
to
0
.1
1
0
.2
7
2
,4
2
2
0
.0
0
7
2
0
.0
0
4
to
0
.0
2
0
.2
2
A
g
e
.
6
3
.5
Lo
g
tr
an
sf
o
rm
e
d
tr
ig
ly
ce
ri
d
e
s
(m
m
o
l/
L)
2
,4
2
0
0
.0
2
2
0
.0
3
to
0
.0
8
0
.3
9
2
,4
1
4
0
.0
0
5
2
0
.0
0
6
to
0
.0
2
0
.4
0
A
g
e
!
6
3
.5
H
D
L-
ch
o
le
st
e
ro
l
(m
m
o
l/
L)
2
,4
2
3
0
.0
7
0
.0
2
to
0
.1
1
0
.0
0
5
2
,4
2
1
0
.0
2
0
.0
1
to
0
.0
3
,
0
.0
0
1
A
g
e
.
6
3
.5
H
D
L-
ch
o
le
st
e
ro
l
(m
m
o
l/
L)
2
,4
2
0
0
.0
3
2
0
.0
1
to
0
.0
7
0
.1
6
2
,4
1
4
0
.0
1
0
.0
0
2
to
0
.0
2
0
.0
2
A
g
e
!
6
3
.5
LD
L-
ch
o
le
st
e
ro
l
(m
m
o
l/
L)
2
,4
2
2
0
.0
2
2
0
.0
6
to
0
.1
0
0
.6
0
2
,4
2
0
0
.0
0
4
2
0
.0
0
9
to
0
.0
2
0
.5
5
A
g
e
.
6
3
.5
LD
L-
ch
o
le
st
e
ro
l
(m
m
o
l/
L)
2
,4
1
6
0
.0
3
2
0
.0
4
to
0
.1
0
0
.4
0
2
,4
1
0
0
.0
2
0
.0
0
2
to
0
.0
3
0
.0
3
A
g
e
!
6
3
.5
Lo
g
tr
an
sf
o
rm
e
d
fa
st
in
g
g
lu
co
se
(m
m
o
l/
L)
2
,4
2
1
0
.0
0
9
2
0
.0
2
to
0
.0
3
0
.4
6
2
,4
2
0
0
.0
0
5
0
.0
0
1
to
0
.0
0
8
0
.0
1
A
g
e
.
6
3
.5
Lo
g
tr
an
sf
o
rm
e
d
fa
st
in
g
g
lu
co
se
(m
m
o
l/
L)
2
,4
1
6
0
.0
1
2
0
.0
1
to
0
.0
3
0
.3
1
2
,4
1
0
0
.0
0
5
0
.0
0
1
to
0
.0
0
8
0
.0
0
9
n
"
O
d
d
s
ra
ti
o
9
5
%
C
I
p
v
a
lu
e
n
O
d
d
s
ra
ti
o
9
5
%
C
I
p
v
a
lu
e
A
g
e
!
6
3
.5
Se
lf
-r
e
p
o
rt
e
d
C
V
D
2
,4
3
6
1
.2
6
0
.8
4
to
1
.8
7
0
.2
6
2
,4
3
6
0
.9
8
0
.9
1
to
1
.0
6
0
.6
5
A
g
e
.
6
3
.5
Se
lf
-r
e
p
o
rt
e
d
C
V
D
2
,4
3
1
0
.8
9
0
.6
6
to
1
.2
0
0
.4
3
2
,4
2
8
1
.0
0
0
.9
4
to
1
.0
6
1
.0
0
A
g
e
!
6
3
.5
Se
lf
-r
e
p
o
rt
e
d
IH
D
2
,4
3
6
1
.3
8
0
.9
3
to
2
.0
5
0
.1
1
2
,4
3
6
1
.0
0
0
.9
2
to
1
.0
8
0
.9
6
A
g
e
.
6
3
.5
Se
lf
-r
e
p
o
rt
e
d
IH
D
2
,4
3
1
0
.9
9
0
.7
1
to
1
.3
9
0
.9
7
2
,4
2
8
0
.9
9
0
.9
2
to
1
.0
6
0
.6
9
{ a
d
ju
st
e
d
fo
r
ag
e
(c
o
n
ti
n
u
o
u
s)
,
e
d
u
ca
ti
o
n
,
p
h
ys
ic
al
ac
ti
vi
ty
,
sm
o
ki
n
g
an
d
u
se
o
f
ap
p
ro
p
ri
at
e
m
e
d
ic
at
io
n
(C
V
D
ri
sk
fa
ct
o
rs
o
n
ly
).
1
p
e
r
al
co
h
o
l
u
n
it
ch
an
g
e
(1
0
g
ra
m
s
e
th
an
o
l/
d
ay
).
"
O
d
d
s
ra
ti
o
is
ap
p
ro
xi
m
at
e
d
b
y
th
e
an
ti
lo
g
ar
it
h
m
o
f
(1
.6
6
p
ro
b
it
co
e
ff
ic
ie
n
t)
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
6
8
0
5
4
.t
0
0
5
Alcohol and CVD Using Mendelian Randomization
PLOS ONE | www.plosone.org 8 July 2013 | Volume 8 | Issue 7 | e68054
Acknowledgments
The Guangzhou Biobank Cohort Study investigators include: Guangzhou
No. 12 Hospital: Dr. WS Zhang, Dr. M Cao, Dr. T Zhu, Dr. B Liu, Prof.
CQ Jiang (Co-PI); The University of Hong Kong: Dr. CM Schooling, Prof.
SM McGhee, Prof. R Fielding, Prof. GM Leung, Prof. TH Lam (Co-PI);
The University of Birmingham: Dr. GN Thomas, Dr. P Adab, Prof. KK
Cheng (Co-PI). We thank Drs. L Xu and T Zhu for facilitating the DNA
extraction. We thank Dr. G Freeman for helpful discussions.
Author Contributions
Conceived and designed the experiments: CMS GML. Performed the
experiments: CMS SLAY BL. Analyzed the data: CMS SLAY BJC.
Contributed reagents/materials/analysis tools: BL. Wrote the paper: CMS
SLAY. Designed the original study and acquired the data: THL KKC
CQJ. Helped design the original study and acquire the data: WSZ BL.
Revised the manuscript critically for important intellectual content and
finally approved the version to be published: CMS SLAY CQJ KKC BJC
BL WSZ THL GML.
References
1. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA (2011) Association
of alcohol consumption with selected cardiovascular disease outcomes: a
systematic review and meta-analysis. BMJ 342: d671.
2. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, et al. (2003) Alcohol
consumption and risk of stroke: a meta-analysis. JAMA 289: 579–588.
3. Carlsson S, Hammar N, Grill V (2005) Alcohol consumption and type 2 diabetes
Meta-analysis of epidemiological studies indicates a U-shaped relationship.
Diabetologia 48: 1051–1054.
4. Center for Nutrition Policy and Promotion USDoA (2011) Dietary Guidelines
for Americans, 2010.
5. Naimi TS, Brown DW, Brewer RD, Giles WH, Mensah G, et al. (2005)
Cardiovascular risk factors and confounders among nondrinking and moderate-
drinking US adults. Am J Prev Med 28: 369–373.
6. Sun W, Schooling CM, Chan WM, Ho KS, Lam TH, et al. (2009) Moderate
alcohol use, health status, and mortality in a prospective Chinese elderly cohort.
Ann Epidemiol 19: 396–403.
7. Schooling CM, Jiang CQ, Lam TH, Zhang WS, Cheng KK, et al. (2009)
Alcohol use and fasting glucose in a developing southern Chinese population: the
Guangzhou Biobank Cohort Study. J Epidemiol Commun H 63: 121–127.
8. Roy A, Prabhakaran D, Jeemon P, Thankappan KR, Mohan V, et al. (2010)
Impact of alcohol on coronary heart disease in Indian men. Atherosclerosis 210:
531–535.
9. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, et al. (2006)
Lifestyle interventions to reduce raised blood pressure: a systematic review of
randomized controlled trials. J Hypertens 24: 215–233.
10. McFadden CB, Brensinger CM, Berlin JA, Townsend RR (2005) Systematic
review of the effect of daily alcohol intake on blood pressure. Am J Hypertens 18:
276–286.
11. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ (1999) Moderate
alcohol intake and lower risk of coronary heart disease: meta-analysis of effects
on lipids and haemostatic factors. BMJ 319: 1523–1528D.
12. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, et al. (2002) Effects of
moderate alcohol intake on fasting insulin and glucose concentrations and
insulin sensitivity in postmenopausal women: a randomized controlled trial.
JAMA 287: 2559–2562.
13. Flanagan DE, Pratt E, Murphy J, Vaile JC, Petley GW, et al. (2002) Alcohol
consumption alters insulin secretion and cardiac autonomic activity. Eur J Clin
Invest 32: 187–192.
14. Harada S, Agarwal DP, Goedde HW, Tagaki S, Ishikawa B (1982) Possible
protective role against alcoholism for aldehyde dehydrogenase isozyme
deficiency in Japan. Lancet 2: 827.
15. Davey-Smith G, Ebrahim S (2004) Mendelian randomization: prospects,
potentials, and limitations. Int J Epidemiol 33: 30–42.
16. Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey-Smith G (2008)
Mendelian randomization: Using genes as instruments for making causal
inferences in epidemiology. Stat Med 27: 1133–1163.
17. Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental
variable approach to causal inference. Stat Methods Med Res 16: 309–330.
18. Harada S, Agarwal DP, Goedde HW (1981) Aldehyde Dehydrogenase-
Deficiency as Cause of Facial Flushing Reaction to Alcohol in Japanese. Lancet
2: 982–982.
19. Chen L, Davey-Smith G, Harbord RM, Lewis SJ (2008) Alcohol intake and
blood pressure: a systematic review implementing a Mendelian randomization
approach. PLoS Med 5: e52.
20. Hao PP, Xue L, Wang XL, Chen YG, Wang JL, et al. (2010) Association
between aldehyde dehydrogenase 2 genetic polymorphism and serum lipids or
lipoproteins: A meta-analysis of seven East Asian populations. Atherosclerosis
212: 213–216.
21. Au Yeung SL, Jiang CQ, Cheng KK, Liu B, Zhang WS, et al. (2012) Evaluation
of Moderate Alcohol Use and Cognitive Function Among Men Using a
Mendelian Randomization Design in the Guangzhou Biobank Cohort Study.
Am J Epidemiol 175: 1021–1028.
22. Jiang C, Thomas GN, Lam TH, Schooling CM, Zhang W, et al. (2006) Cohort
profile: The Guangzhou Biobank Cohort Study, a Guangzhou-Hong Kong-
Birmingham collaboration. Int J Epidemiol 35: 844–852.
23. Rassen JA, Schneeweiss S, Glynn RJ, Mittleman MA, Brookhart MA (2009)
Instrumental variable analysis for estimation of treatment effects with
dichotomous outcomes. Am J Epidemiol 169: 273–284.
24. He J, Gu DF, Wu XG, Reynolds K, Duan XF, et al. (2005) Major causes of
death among men and women in China. N Engl J Med 353: 1124–1134.
25. Au Yeung SL, Jiang C, Cheng KK, Liu B, Zhang W, et al. (2013) Is aldehyde
dehydrogenase 2 a credible genetic instrument for alcohol use in Mendelian
randomization analysis in Southern Chinese men?. Int J Epidemiol 42: 318–328.
26. Shai I, Wainstein J, Harman-Boehm I, Raz I, Fraser D, et al. (2007) Glycemic
effects of moderate alcohol intake among patients with type 2 diabetes. Diabetes
Care 30: 3011–3016.
27. Zhang Y, Ren J (2011) ALDH2 in alcoholic heart diseases: Molecular
mechanism and clinical implications. Pharmacol Ther 132: 86–95.
28. Muramatsu T, Wang ZC, Fang YR, Hu KB, Yan H, et al. (1995) Alcohol and
aldehyde dehydrogenase genotypes and drinking behavior of Chinese living in
Shanghai. Hum Genet 96: 151–154.
29. Pierce BL, Ahsan H, Vanderweele TJ (2011) Power and instrument strength
requirements for Mendelian randomization studies using multiple genetic
variants. Int J Epidemiol 40: 740–752.
30. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA (2011) Effect of
alcohol consumption on biological markers associated with risk of coronary heart
disease: systematic review and meta-analysis of interventional studies. BMJ 342:
d636.
31. Johansen D, Friis K, Skovenborg E, Gronbaek M (2006) Food buying habits of
people who buy wine or beer: cross sectional study. BMJ 332: 519–522.
32. Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, et al. (2006) Association of
the metabolic syndrome with vascular disease in an older Chinese population:
Guangzhou Biobank Cohort Study. J Endocrinol Invest 29: 989–996.
33. Glymour MM, Tchetgen Tchetgen EJ, Robins JM (2012) Credible Mendelian
Randomization Studies: Approaches for Evaluating the Instrumental Variable
Assumptions. Am J Epidemiol 175: 332–339.
34. Pierce BL, Vanderweele TJ (2012) The effect of non-differential measurement
error on bias, precision and power in Mendelian randomization studies.
Int J Epidemiol 41: 1383–1393.
35. Schooling CM, Wenjie S, Ho SY, Chan WM, Tham MK, et al. (2008)
Moderate Alcohol Use and Mortality from Ischaemic Heart Disease: A
Prospective Study in Older Chinese People. PLoS One 3: -.
36. Agarwal DP (2002) Cardioprotective effects of light-moderate consumption of
alcohol: A review of putative mechanisms. Alcohol Alcoholism 37: 409–415.
37. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, et
al. (2012) Plasma HDL cholesterol and risk of myocardial infarction: a
mendelian randomisation study. Lancet 380: 572–580.
38. Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, et al. (2009)
Association between change in high density lipoprotein cholesterol and
cardiovascular disease morbidity and mortality: systematic review and meta-
regression analysis. BMJ 338.
39. Haase CL, Tybjaerg-Hansen A, Ali Qayyum A, Schou J, Nordestgaard BG, et
al. (2011) LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A
Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals.
J Clin Endocrinol Metab 97: E248–E256.
40. Sin DD, Wu LL, Man SFP (2005) The relationship between reduced lung
function and cardiovascular mortality – A population-based study and a
systematic review of the literature. Chest 127: 1952–1959.
41. Sisson JH, Stoner JA, Romberger DJ, Spurzem JR, Wyatt TA, et al. (2005)
Alcohol intake is associated with altered pulmonary function. Alcohol 36: 19–30.
42. Sierksma A, Sarkola T, Eriksson CJ, van der Gaag MS, Grobbee DE, et al.
(2004) Effect of moderate alcohol consumption on plasma dehydroepiandros-
terone sulfate, testosterone, and estradiol levels in middle-aged men and
postmenopausal women: a diet-controlled intervention study. Alcohol Clin Exp
Res 28: 780–785.
43. Kupelian V, Chiu GR, Araujo AB, Williams RE, Clark RV, et al. (2010)
Association of sex hormones and C-reactive protein levels in men. Clin
Endocrinol (Oxf) 72: 527–533.
Alcohol and CVD Using Mendelian Randomization
PLOS ONE | www.plosone.org 9 July 2013 | Volume 8 | Issue 7 | e68054
